Home / Resources / On-Demand Webinar / Combining active pharmaceutical ingredients (APIs): MPT Development & Regulatory Considerations
Combining active pharmaceutical ingredients (APIs): MPT Development & Regulatory Considerations
June 17, 2021
On-Demand Webinar

This fourth webinar in the “Let’s Talk MPTs” learning series will provide MPT product developers and other stakeholders an overview of clinical development and regulatory considerations when developing products that combine one or more active pharmaceutical ingredients (APIs) into an MPT product.

Speakers

• Deven Shah – Chemistry, Manufacturing, & Control (CM&C) Lead at Certara
• Kevin Hershberger – Vice President of Integrated Drug Development at Certara
• Tamra Goodrow – Regulatory Consultant & Principal at Deer Run Regulatory Consulting

Back to top